$78.78
-4.50-5.4%
Last update: Nov 5, 3:28 PM
Disc Medicine Inc (IRON) Stock Price, Quote, News & History
IRONNASDAQ
Disc Medicine reports positive Phase 3 results for bitopertin in EPP, meeting all primary and secondary endpoints. NDA resubmission planned.
You can purchase shares of Disc Medicine (NASDAQ:IRON) through any online brokerage.
Other companies in Disc Medicine’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Disc Medicine has a consensus price target of $102.29.
The stock price for Disc Medicine (NASDAQ: IRON) is $78.78 last updated November 5, 2026 at 3:28 PM EST.
There are no upcoming dividends for Disc Medicine.
Disc Medicine does not have any upcoming earnings scheduled.
There is no upcoming split for Disc Medicine.
Disc Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation...
